These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1188183)

  • 21. Cholinergic-dopaminergic interactions in experimental catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1983; 81(1):24-7. PubMed ID: 6415727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasodilatation produced by apomorphine in the hindleg of the dog.
    Buylaert WA; Willems JL; Bogaert MG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):738-46. PubMed ID: 864606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic influences on opioids activity in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):85-92. PubMed ID: 6891961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
    Buccafusco JJ; Bain JN
    Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of dopaminergic substances on the antinocifensive action of arecoline].
    Kraft U; Kraft H; Andreas K
    Acta Biol Med Ger; 1979; 38(4):649-52. PubMed ID: 525142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of dopaminergic mechanism in morphine induced Straub tail response.
    Jaju BP; Srivastava YP
    Indian J Exp Biol; 1984 Aug; 22(8):424-7. PubMed ID: 6510975
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats.
    Maeda N; Matsuoka N; Yamaguchi I
    Jpn J Pharmacol; 1994 Sep; 66(1):59-66. PubMed ID: 7861668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of apomorphine-induced aggression by morphine or neuroleptics: differential alteration by antimuscarinics and naloxone.
    Gianutsos G; Lal H
    Pharmacol Biochem Behav; 1976 Jun; 4(6):639-42. PubMed ID: 988593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential neurohumoral modulation of myoclonic and clonic seizures.
    Greer CA; Alpern HP
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):74-85. PubMed ID: 34368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs.
    Yonkov DI; Georgiev VP; Opitz MJ
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):203-6. PubMed ID: 3724295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the role of dopaminergic systems in morphine-induced motor activity. Comparison with noradrenergic and cholinergic systems.
    VanderWende C; Spoerlein MT; Can Luc N
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):79-88. PubMed ID: 1153864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors.
    Rezayof A; Hosseini SS; Zarrindast MR
    Behav Brain Res; 2009 Sep; 202(2):171-8. PubMed ID: 19463698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.